Nonhuman primate IgA: Genetic heterogeneity and interactions with CD89

Journal of Immunology

Volumn 180, Issue 7, 2008, Pages 4816-4824

  Rogers, Kenneth A ^a   Jayashankar, Lakshmi ^a   Scinicariello, Franco ^b   Attanasio, Roberta ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD89 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN HEAVY CHAIN ALPHA; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG; FC RECEPTOR; FC(ALPHA) RECEPTOR; IMMUNOGLOBULIN FC FRAGMENT; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE SEQUENCE; GENETIC HETEROGENEITY; GLYCOSYLATION; HINGE REGION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; HELA CELL; HETEROZYGOTE; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; HELA CELLS; HETEROZYGOTE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ALPHA-CHAINS; IMMUNOGLOBULIN FC FRAGMENTS; MOLECULAR SEQUENCE DATA; PRIMATES; PROTEIN BINDING; RECEPTORS, FC; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 44449178879     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.7.4816     Document Type: Article

References (57)

1. Carlsson, H. E., S. J. Schapiro, I. Farah, and J. Hau. 2004. Use of primates in research: A global overview. Am. J. Primatol. 63: 225-237.
2. Yang, X. D., J. R. Corvalan, P. Wang, C. M. Roy, and C. G. Davis. 1999. Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states. J. Leukocyte Biol. 66: 401-410.
3. Yang, X. D., X. C. Jia, J. R. Corvalan, P. Wang, C. G. Davis, and A. Jakobovits. 1999. Eradication of established tumors by a fully human monoclonal antibody to the epidermal growth factor receptor without concomitant chemotherapy. Cancer Res. 59: 1236-1243.
4. Hinton, P. R., M. G. Johlfs, J. M. Xiong, K. Hanestad, K. C. Ong, C. Bullock, S. Keller, M. T. Tang, J. Y. Tso, M. Vasquez, and N. Tsurushita. 2004. Engineered human IgG antibodies with longer serum half-lives in primates. J. Biol. Chem. 279: 6213-6216.
5. Hahn, C. S., O. G. French, P. Foley, E. N. Martin, and R. P. Taylor. 2001. Bispecific monoclonal antibodies mediate binding of dengue virus to erythrocytes in a monkey model of passive viremia. J. Immunol. 166: 1057-1065.
6. Weinberg, A. D., C. Thalhofer, N. Morris, J. M. Walker, D. Seiss, S. Wong, M. K. Axthelm, L. J. Picker, and W. J. Urba. 2006. Anti-OX40 (CD134) administration to nonhuman primates: immunostimulatory effects and toxicokinetic study. J. Immunother. 29: 575-585.
7. 't Hart, B. A., H. P. Brok, E. Remarque, J. Benson, G. Treacy, S. Amor, R. Q. Hintzen, J. D. Laman, J. Bauer, and E. L. Blezer. 2005. Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody. J. Immunol. 175: 4761-4768.
8. Rogers, K. A., F. Scinicariello, and R. Attanasio. 2006. IgG Fc receptor III ho-mologues in nonhuman primate species: genetic characterization and ligand interactions. J. Immunol. 177: 3848-3856.
9. Hexham, J. M., L. Carayannopoulos, and J. D. Capra. 1997. Structure and function in IgA. Chem. Immunol. 65: 73-87.
10. Janoff, E. N., C. Fasching, J. M. Orenstein, J. B. Rubins, N. L. Opstad, and A. P. Dalmasso. 1999. Killing of Streptococcus pneumoniae by capsular poly-saccharide-specifc polymeric IgA, complement and phagocytes. J. Clin. Invest. 104: 1139-1147.
11. 11.van Egmond, M., C. A. Damen, A. B. van Spriel, G. Vidarsson, E. van Garderen, and J. G. van de Winkel. 2001. IgA and the IgA Fc receptor. Trend. Immunol. 22:205-211.
12. Yan, H., M. E. Lamm, E. Bjorling, and Y. T. Huang. 2002. Multiple functions of IgA in mucosal defense against viruses: an in vitro measles virus model. J. Virol. 76: 10972-10979.
13. Langford, T. D., M. P. Housley, M. Boes, J. Chen, M. F. Kagnoff, F. D. Gillin, and L. Eckmann. 2002. Central importance of IgA in host defense against Giardia spp. Infect. Immun. 70: 11-18.
14. Motegi, Y., H. Kita, M. Kato, and A. Morikawa. 2000. Role of secretory IgA, secretory component and eosinophils in mucosal inflammation. Int. Arch. Allergy Immunol. 122:S25-S27.
15. Pleass, R. J., J. I. Dunlop, C. M. Anderson, and J. M. Woof. 1999. Identification of residues in the CH2/CH3 domain interface of IgA essential for interaction with the human Fca receptor CD89. J. Biol. Chem. 274: 23508-23514.
16. Goldblum, R. M. 1990. The role of IgA in local immune protection. J. Clin. Immunol. 10:64S-70S.
17. van der Boog, P. J., G. van Zandbergen, J. W. de Fijter, N. Klar-Mohamad, A. van Seggelen, P. Brandtzaeg, M. R. Daha, and C. van Kooten. 2002. FcalphaRI/CD89 circulates in human serum covalently linked in a polymeric state. J. Immunol. 168: 1252-1258.
18. Flanagan, J. G., M. P. Lefranc, and T. H. Rabbitts. 1984. Mechanisms ofdiver-gence and convergence of the human immunoglobulin α 1 and α 2 constant region gene sequences. Cell 36: 681-688.
19. Lefranc, M.-P., and G. Lefranc. 2001. The Immunoglobulin FactsBook. Academic Press, San Diego, CA.
20. Kawamura, S., H. Tanabe, Y. Watanabe, K. Kurosaki, N. Saitou, and S. Ueda. 1991. Evolutionary rate of immunoglobulin a noncoding region is greater in hominoids than in Old World monkeys. Mol. Biol. Evol. 8: 743-752.
21. Shimizu, A., N. Takahashi, Y. Yaoita, and T. Honjo. 1982. Organization of the constant-region gene family of the mouse immunoglobulin heavy chain. Cell 28:499-506.
22. Sumiyama, K., N. Saitou, andS. Ueda. 2002. Adaptive evolution of the IgA hinge region in primates. Mol. Biol. Evol. 19: 1093-1099.
23. Sumiyama, K., S. Kawamura, O. Takenaka, and S. Ueda. 1998. A high sequence variety in the Immunoglobulin C α hinge region among Old World monkeys. Anthropo. Sci. 106: 31-39.
24. Kawamura, S., K. Omoto, and S. Ueda. 1990. Evolutionary hypervariability in the hinge region of the immunoglobulin a gene. J. Mol. Biol. 215: 201-206.
25. Scinicariello, F., and R. Attanasio. 2001. Intraspecies heterogeneity of immuno-globulin a-chain constant region genes in rhesus macaques. Immunology 103:441-448.
26. Scinicariello, F., F. Masseoud, L. Jayashankar, and R. Attanasio. 2006. Sooty mangabey (Cercocebus torquatus atys) IGHG and IGHA genes. Immunogenetics 58: 955-965.
27. Phillips-Quagliata, J. M. 2002. Mouse IgA allotypes have major differences in their hinge regions. Immunogenetics 53: 1033-1038.
28. Navarro, P., R. K. Christenson, G. Ekhardt, B. Bosworth, J. K. Lunney, M. Rothschild, J. Lemke, and J. E. Butler. 2000. Genetic differences in the frequency of the hinge variants of porcine IgA is breed dependent. Vet. Immunol. Immunopathol. 73: 287-295.
29. Presta, L. G. 2002. Engineering antibodies for therapy. Curr. Pharm. Biotechnol. 3: 237-256.
30. Lefranc, M.-P., V. Giudicelli, Q. Kaas, E. Duprat, J. Jabado-Michaloud, D. Scaviner, C. Ginestoux, O. Clement, D. Chaume, and G. Lefranc. 2005. IMGT, the international ImMunoGeneTics information system. Nucleic. Acid Res. 33:D593-D597.
31. Lefranc, M.-P., C. Pommie, Q. Kaas, E. Duprat, N. Bosc, D. Guiraudou, C. Jean, M. Ruiz, I. Da Piedade, M. Rouard, E. Foulquier, V. Thouvenin, and G. Lefranc. 2005. IMGT unique numbering for immunoglobulin and T cell receptor constant domains and Ig superfamily C-like domains. Dev Comp Immunol. 29: 185-203.
32. Scinicariello, F., C. N. Engleman, L. Jayashankar, H. M. McClure, and R. Attanasio. 2004. Rhesus macaque antibody molecules: sequences and heterogeneity of α and γ constant regions. Immunology 111: 66-74.
33. Norderhaug, L., T. Olafsen, T. E. Michaelsen, and I. Sandlie. 1997. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J. Immunol. Methods. 204: 77-87.
34. Oi, V. T., S. L. Morrison, L. A. Herzenberg, and P. Berg. 1983. Immunoglobulin gene expression in transformed lymphoid cells. Proc. Natl. Acad. Sci. USA 80:825-829.
35. Rogers, K. A., F. Scinicariello, and R. Attanasio. 2004. Identification and characterization of macaque CD89 (IgA Fc Receptor). Immunology 113: 178-186.
36. Qiu, J., G. P. Brackee, and A. G. Plaut. 1996. Analysis of the specificity of bacterial immunoglobulin I (IgA) proteases by a comparative study of ape serum IgAs as substrates. Infect. Immun. 64: 933-937.
37. Chintalacharuvu, K. R., P. D. Chuang, A. Dragoman, C. Z. Fernandez, J. Qiu, A. G. Plaut, K. R. Trinh, F. A. Gala, and S. L. Morrison. 2003. Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 protease requires structures in the Fc region of IgA. Infect. Immun. 71: 2563-2570.
38. Drescher, B., T. Witte, and R. E. Schmidt. 2003. Glycosylation of FcγRIII in N163 as mechanism of regulation receptor affinity. Immunology 110: 335-340.
39. Letvin, N. L. 2006. Progress and obstacles in the development of an AIDS vaccine. Nat. Rev. Immunol. 6: 930-939.
40. Joag, S. V., R. J. Adams, L. Foresman, D. Galbreath, M. C. Zink, D. M. Pinson, H. McClure, and O. Narayan. 1994. Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology 200: 436-446.
41. Ling, B., R. S. Veazey, A. Luckay, C. Penedo, K. Xu, J. D. Lifson, and P. A. Marx. 2002. SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. AIDS 16: 1489-1496.
42. Trichel, A. M., P. A. Rajakumar, and M. Murphey-Corb. 2002. Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J. Med. Primatol. 31: 171-178.
43. Marthas, M. L., D. Lu, M. C. Penedo, A. G. Hendrickx, and C. J. Miller. 2001. Titration of a SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: transmission efficiency, viral loads, and antibody responses. AIDS Res. Hum. Retroviruses. 17: 1455-1466.
44. Reimann, K. A., P. A. Parker, M. S. Seaman, K. Beaudry, M. Beddall, L. Peterson, K. C. Williams, R. S. Veazey, D. C. Montefiori, J. R. Mascola, G. J. Nabel, and N. L. Letvin. 2005. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J. Virol. 79: 8878-8885.
45. Villinger, F., T. M. Folks, S. Lauro, J. D. Powell, J. B. Sundstrom, A. Mayne, and A. A. Ansari. 1996. Immunological and virological studies of natural SIV infection of disease-resistant nonhuman primates. Immunol. Lett. 51: 59-68.
46. Picker, L. J. 2006. Immunopathogenesis of acute AIDS virus infection. Curr. Opin. Immunol. 18: 399-405.
47. Brenchley, J. M., D. A. Price, T. W. Schacker, T. E. Asher, G. Silvestri, S. Rao, Z. Kazzaz, E. Bornstein, O. Lambotte, D. Altmann, B. R. Blazar, B. Rodriguez, L. Teixeira-Johnson, A. Landay, J. N. Martin, F. M. Hecht, L. J. Picker, M. M. Lederman, S. G. Deeks, and D. C. Douek. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Immunol. 12: 1365-1371.
48. Herr, A. B., E. R. Ballister, and P. J. Bjorkman. 2003. Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc. Nature 423: 614-620.
49. Pleass, R. J., P. K. Dehal, M. J. Lewis, and J. M. Woof. 2003. Limited role of charge matching in the interaction of human immunoglobulin A with the immu-noglobulin A Fc receptor (FcαRI) CD89. Immunology 109: 331-335.
50. Decot, V., G. Woerly, M. Loyen, S. Loiseau, B. Quatannens, M. Capron, and D. Dombrowicz. 2005. Heterogeneity of expression of IgA receptors by human, mouse, and rat eosinophils. J. Immunol. 174: 628-635.
51. Launay, P., B. Grossetête, M. Arcos-Fajardo, E. Gaudin, S. P. Torres, L. Beaudoin, N. Patey-Mariaud de Serre, A. Lehuen, and R. C. Monteiro. 2000. Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J. Exp. Med. 191: 1999-2009.
52. Van der Boog, P. J. M., J. W. de Fijter, C. van Kooten, R. van der Holst R, A. van Seggelen, L. A. van Es, and M. R. Daha. 2003. Complexes of IgA with FcalphaI/CD89 are not specific for primary IgA nephropathy. Kidney Int. 63:514-521.
53. Van der Boog, P. J. M., C. van Kooten, G. van Zandbergen, N. Klar-Mohamad, Bb. Oortwijn, N. A. Bos, A. van Remoortere, C. H. Hokke, J. W. de Fijter, and M. R. Daha. 2004. Injection of recombinant FcalphaRI/CD89 in mice does not induce mesangial IgA deposition. Nephrol. Dial. Transplant. 19: 2729-2736.
54. Penedo, M. C., R. E. Bontrop, C. M. Heijmans, N. Otting, R. Noort, A. J. Rouweler, N. de Groot, N. G. de Groot, T. Ward, and G. G. Doxiadis. 2005. Microsatellite typing of the rhesus macaque MHC region. Immunogenetics 57:198-209.
55. Muhl, T., M. Krawczak, P. Tan Haaft, G. Hunsmann, and U. Saurmann. 2002. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 169: 3438-3446.
56. Lefranc, M.-P., and T. H. Rabbits. 1984. Human immunoglobulin heavy chain A2 gene allotype determination by restriction fragment length polymorphism. Nucleic Acids Res. 12: 1303-1311.
57. Bensmana, M., P. Chuchana, P. G. Lefranc, and M.-P. Lefranc. 1991. Sequence of the CH1 and hinge-CH2 exons of the human immunoglobulin IGHA2 A2m(2) allele: comparison with the nonallelic and allelic IGHA genes. Cytogenet. Cell Genet. 56: 128.